PHILADELPHIA, Jan. 12, 2017 -- Chemtura Corporation (NYSE:CHMT) (EURONEXT:CHMT) announced it will release its Fourth Quarter and Full Year 2016 earnings and file its Annual Report on Form 10-K on Wednesday, February 22, 2017, after the market closes.
The Company will host a teleconference to review these results on Thursday, February 23, 2017 at 9:00 a.m. (EST). A webcast of the teleconference will be available on the Investor Relations section of Company’s web site at www.chemtura.com.
Interested parties are asked to dial in approximately ten (10) minutes prior to the start time.
The call-in numbers are:
Domestic Toll-Free: (877) 494-3128
International: (404) 665-9523
The conference ID code is: 48493850
A replay of the call will be available for thirty days, starting at 10:00 a.m. (EST) Thursday, February 23, 2017. To access the replay, call (855) 859-2056, or
(404) 537-3406, and enter access code 48493850
WEBCAST LINK:
The webcast link below will be activated on the morning of the call.
http://edge.media-server.com/m/p/6i7ohzsw
Chemtura Corporation, with 2015 sales of $1.7 billion, is a global manufacturer and marketer of specialty chemicals. Additional information concerning Chemtura is available at www.chemtura.com.
Matthew Sokol Director, Investor Relations and Corporate Development Tel: (203) 573-2153


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



